Cogent Biosciences Announces Presentation at the 42nd Annual J.P. Morgan Healthcare Conference

January 2, 2024

https://www.globenewswire.com/news-release/2024/01/02/2802625/0/en/Cogent-Biosciences-Announces-Presentation-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html

WALTHAM, Mass. and BOULDER, Colo., Jan. 02, 2024 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq:COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that Andrew Robbins, President and Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 9, 2024 at 4:30 p.m. PT/7:30 p.m. ET.

Read more at globenewswire.com

Related news for (COGT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.